Skip to main content

OPK

Opko Health, Inc.

Company with tickers: OPK

CIK
944809
CUSIP
68375N103
Shares Outstanding
755,092,256
Investor Relations
https://www.opko.com/investors
13F Activity (30d)
74 filings 70 filers

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Line Item Value
Revenue $1,400,000
Revenue (ASC 606) $124,196,000
Cost of Revenue
Gross Profit $45,755,000
Operating Expenses
Research & Development $29,199,000
Operating Income $-51,017,000
Net Income $-54,848,000
EPS (Basic) $-0.07
EPS (Diluted) $-0.07

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

By Geography (USD)

Component 2023-12-31 2024-12-31 2025-12-31
United States $597,822,000 $546,300,000 $436,061,000
Chile $68,491,000 $65,049,000 $62,377,000
Ireland $141,465,000 $48,397,000 $51,401,000
Spain $23,517,000 $24,634,000 $26,725,000
Mexico $20,216,000 $23,867,000 $25,520,000
Other Countries $2,246,000 $3,123,000 $4,273,000
Israel $9,738,000 $1,772,000 $522,000

By Product & Service (USD)

Component 2023-12-31 2024-12-31 2025-12-31
Service $515,275,000 $480,667,000 $370,275,000
Product $167,557,000 $155,111,000 $156,924,000
Transfer Of Intellectual Property And Other $180,663,000 $77,364,000 $79,680,000
Rayaldee $67,547,000 $69,299,000 $59,389,000